US-based implants maker RTI Surgical has launched a new technology to offer surgeons with three-dimensional (3D) printed polymer implant material for spinal interbody fusion.
The new TETRAfuse 3D Technology is said to provide trabecular bone ingrowth with simultaneous maintenance of radiolucency and mechanical properties similar to a bone.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
TETRAfuse 3D printing process is designed to create a nano-rough surface on the whole implant to allow bony ingrowth across the disc space from endplate to endplate for deep implant osseointegration.
RTI Surgical CEO Camille Farhat said: “We are excited about the promise this technology holds for our surgeon customers and their patients.
“Being the first to offer surgeons a 3D printed interbody polymer optimised to participate in fusion marks another significant milestone for RTI in our quest to continuously deliver relevant and innovative products without compromise.”
The ability of the new technology to combine fusion process, bone-like mechanical properties and radiolucent imaging is intended to provide surgeons with the osseointegrative advantages of both titanium and allograft bone, along with the benefits of PEEK.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataRTI Surgical is planning to manufacture a variety of products and derivative offerings using its new TETRAfuse 3D Technology.
With four manufacturing plants in the US and Europe, the firm primarily focuses on providing safe biologic, metal and synthetic implants to surgeons.
The firm’s portfolio of sports medicine, general surgery, spine, orthopaedic, trauma and cardiothoracic implants are available in approximately 50 countries.
